EASY BIO (353810) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, EASY BIO (353810) reported revenue of 476.9 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025476.9 billion KRW45.0 billion KRW29.3 billion KRW[source]
2024384.3 billion KRW32.4 billion KRW19.9 billion KRW[source]
2023165.4 billion KRW20.6 billion KRW16.1 billion KRW[source]
2022155.6 billion KRW16.2 billion KRW9.3 billion KRW[source]
2021129.5 billion KRW16.8 billion KRW10.8 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025248.5 billion KRW168.2 billion KRW80.3 billion KRW[source]
2024245.6 billion KRW171.9 billion KRW73.7 billion KRW[source]
2023164.2 billion KRW105.0 billion KRW59.3 billion KRW[source]
2022150.0 billion KRW101.3 billion KRW48.7 billion KRW[source]
2021109.5 billion KRW67.3 billion KRW42.2 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice